These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10614194)

  • 21. Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.
    Arjomand H; Cohen M; Ezekowitz MD
    J Invasive Cardiol; 2004 May; 16(5):271-8. PubMed ID: 15152137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of anticoagulation in patients with bioprostheses.
    Gherli T; Colli A; Nicolini F
    J Heart Valve Dis; 2004 May; 13 Suppl 1():S88-9. PubMed ID: 15225014
    [No Abstract]   [Full Text] [Related]  

  • 23. Review: anticoagulants may be better than antiplatelet agents for nonfatal stroke but not other vascular or fatal events in nonrheumatic AF.
    Ebrahim S; Taylor F
    ACP J Club; 2001; 135(2):A17. PubMed ID: 11571899
    [No Abstract]   [Full Text] [Related]  

  • 24. Endogenous thrombin potential (ETP) in plasma from patients with AMI during antithrombotic treatment.
    Brodin E; Seljeflot I; Arnesen H; Hurlen M; Appelbom H; Hansen JB
    Thromb Res; 2009 Feb; 123(4):573-9. PubMed ID: 18474393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there less benefit from warfarin in diabetics after myocardial infarction? The numbing complexities of assessing anticoagulant and antiplatelet therapy in the diabetic patient.
    Smith DA
    Cardiology; 2008; 111(3):158-60. PubMed ID: 18434718
    [No Abstract]   [Full Text] [Related]  

  • 26. Preventing stroke in patients with atrial fibrillation.
    Edds W; Newton W
    J Fam Pract; 2000 Jan; 49(1):8-9. PubMed ID: 10678330
    [No Abstract]   [Full Text] [Related]  

  • 27. Antiplatelet versus anticoagulant therapies in advanced age: an unfinished task.
    García-Honrubia A; Roldán V; Climent V; Sogorb F; Marín F
    Int J Cardiol; 2006 Jun; 110(2):271-2. PubMed ID: 16343666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antithrombotic therapy in heart failure.
    Verheugt FW
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):277-8. PubMed ID: 16716103
    [No Abstract]   [Full Text] [Related]  

  • 29. Short-term triple therapy with aspirin, warfarin, and a thienopyridine among patients undergoing percutaneous coronary intervention.
    Porter A; Konstantino Y; Iakobishvili Z; Shachar L; Battler A; Hasdai D
    Catheter Cardiovasc Interv; 2006 Jul; 68(1):56-61. PubMed ID: 16763985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiplatelet and anticoagulant therapy in patients with advanced heart failure.
    Lip GY; Chung I
    Thromb Res; 2005; 116(4):275-7. PubMed ID: 16038710
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of aspirin and warfarin on fatal and non-fatal heart attacks.
    Born G
    Lancet; 1999 Oct; 354(9188):1472. PubMed ID: 10543693
    [No Abstract]   [Full Text] [Related]  

  • 32. Better stroke prevention.
    Ornato JP
    Health News; 2001 Apr; 7(4):1-2. PubMed ID: 11303474
    [No Abstract]   [Full Text] [Related]  

  • 33. Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation.
    Orford JL; Fasseas P; Melby S; Burger K; Steinhubl SR; Holmes DR; Berger PB
    Am Heart J; 2004 Mar; 147(3):463-7. PubMed ID: 14999195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticoagulants for prevention of ischemic stroke: current concepts.
    Mohr JP
    Adv Neurol; 2003; 92():263-70. PubMed ID: 12760192
    [No Abstract]   [Full Text] [Related]  

  • 35. Warfarin versus aspirin in patients with reduced cardiac ejection fraction (WARCEF): rationale, objectives, and design.
    Pullicino P; Thompson JL; Barton B; Levin B; Graham S; Freudenberger RS;
    J Card Fail; 2006 Feb; 12(1):39-46. PubMed ID: 16500579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment protocol of cerebral vascular accident].
    Biller J
    Rev Neurol; 1997 Jan; 25(137):114. PubMed ID: 9091192
    [No Abstract]   [Full Text] [Related]  

  • 37. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful lysis of coronary thrombi by long term warfarin treatment after a failed course of tirofiban infusion.
    Boztosun B; Gunes Y; Kirma C; Barutcu I
    Int J Cardiol; 2006 Mar; 108(1):114-6. PubMed ID: 16516705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medications used to prevent adhesion and clotting.
    Lassiter TF
    Lippincotts Prim Care Pract; 2000; 4(6):619-32; quiz 633-5. PubMed ID: 11933375
    [No Abstract]   [Full Text] [Related]  

  • 40. Ask the doctor. I am 95 years old and recently began treatment for early macular degeneration in one eye. My retinologist said that PreserVision might help protect the other eye. But she cautioned that it contains a large dose of vitamin E, which could cause a bleeding problem with the Coumadin I take because of a mechanical aortic valve. What would you suggest?
    Goldhaber SZ
    Harv Heart Lett; 2010 Apr; 20(8):7. PubMed ID: 20590010
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.